Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Clin Linguist Phon ; 36(8): 721-737, 2022 08 03.
Artículo en Inglés | MEDLINE | ID: mdl-36044010

RESUMEN

This article describes the phonology of a Granada Spanish-speaking 4-year-old boy with Protracted Phonological Development (PPD) from the perspective of constraint-based nonlinear phonology. Although he had acquired basic word structure and a near-complete repertoire of vowels and consonants, he had difficulties producing more complex word structures (multisyllabic words, clusters, diphthongs) and producing sequences of consonant manner and place features across vowels. The analysis outlines his strengths and needs in phonological development, and proposes an intervention plan to address constraints on complexity and sequences.


Asunto(s)
Lenguaje , Fonética , Preescolar , Humanos , Masculino , Medición de la Producción del Habla
2.
Mol Cancer Ther ; 17(10): 2123-2135, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30018048

RESUMEN

High-grade serous ovarian cancer (HGSOC) is a lethal gynecological malignancy with a need for new therapeutics. Many of the most widely used chemotherapeutic drugs are derived from natural products or their semi-synthetic derivatives. We have developed potent synthetic analogues of a class of compounds known as phyllanthusmins, inspired by natural products isolated from Phyllanthus poilanei Beille. The most potent analogue, PHY34, had the highest potency in HGSOC cell lines in vitro and displayed cytotoxic activity through activation of apoptosis. PHY34 exerts its cytotoxic effects by inhibiting autophagy at a late stage in the pathway, involving the disruption of lysosomal function. The autophagy activator, rapamycin, combined with PHY34 eliminated apoptosis, suggesting that autophagy inhibition may be required for apoptosis. PHY34 was readily bioavailable through intraperitoneal administration in vivo where it significantly inhibited the growth of cancer cell lines in hollow fibers, as well as reduced tumor burden in a xenograft model. We demonstrate that PHY34 acts as a late-stage autophagy inhibitor with nanomolar potency and significant antitumor efficacy as a single agent against HGSOC in vivo This class of compounds holds promise as a potential, novel chemotherapeutic and demonstrates the effectiveness of targeting the autophagic pathway as a viable strategy for combating ovarian cancer. Mol Cancer Ther; 17(10); 2123-35. ©2018 AACR.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Apoptosis/efectos de los fármacos , Autofagia/efectos de los fármacos , Cistadenocarcinoma Seroso/metabolismo , Cistadenocarcinoma Seroso/patología , Neoplasias Ováricas/metabolismo , Neoplasias Ováricas/patología , Animales , Antineoplásicos Fitogénicos/química , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Cistadenocarcinoma Seroso/tratamiento farmacológico , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Lisosomas/metabolismo , Clasificación del Tumor , Estadificación de Neoplasias , Neoplasias Ováricas/tratamiento farmacológico , Carga Tumoral/efectos de los fármacos , Ensayos Antitumor por Modelo de Xenoinjerto
3.
Bioorg Med Chem ; 26(9): 2354-2364, 2018 05 15.
Artículo en Inglés | MEDLINE | ID: mdl-29656990

RESUMEN

A series of arylnaphthalene lignan lactones based on the structure of the phyllanthusmins, a class of potent natural products possessing diphyllin as the aglycone, has been synthesized and screened for activity against multiple cancer cell lines. SAR exploration was performed on both the carbohydrate and lactone moieties of this structural class. These studies have revealed the importance of functionalization of the carbohydrate hydroxy groups with both acetylated and methylated analogues showing increased potency relative to those with unsubstituted sugar moieties. In addition, the requirement for the presence and position of the C-ring lactone has been demonstrated through reduction and selective re-oxidation of the lactone ring. The most potent compound in this study displayed an IC50 value of 18 nM in an HT-29 assay with several others ranging from 50 to 200 nM. In an effort to elucidate their potential mechanism(s) of action, the DNA topoisomerase IIa inhibitory activity of the most potent compounds was examined based on previous reports of structurally similar compounds, but does not appear to contribute significantly to their antiproliferative effects.


Asunto(s)
Antineoplásicos/farmacología , Glicósidos/farmacología , Lactonas/farmacología , Lignanos/farmacología , Naftalenos/farmacología , Antineoplásicos/síntesis química , Antineoplásicos/química , Benzodioxoles/farmacología , Línea Celular Tumoral , Ensayos de Selección de Medicamentos Antitumorales , Etopósido/farmacología , Glicósidos/síntesis química , Glicósidos/química , Humanos , Lactonas/síntesis química , Lactonas/química , Lignanos/síntesis química , Lignanos/química , Estructura Molecular , Naftalenos/síntesis química , Naftalenos/química , Estereoisomerismo , Relación Estructura-Actividad , Inhibidores de Topoisomerasa II/síntesis química , Inhibidores de Topoisomerasa II/química , Inhibidores de Topoisomerasa II/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...